Please login to the form below

Not currently logged in


This page shows the latest Zogenix news and features for those working in and with pharma, biotech and healthcare.

Purdue gets FDA nod for abuse-deterrent painkiller

Purdue gets FDA nod for abuse-deterrent painkiller

The new product will compete in the marketplace against products such as Zogenix' 12-hour Zohydro ER (hydrocodone), another long-acting opioid analgesic which was approved by the FDA last year ... Zogenix filed for approval of a line extension based on

Latest news

  • Dancing with the Deval Dancing with the Deval

    One critic (among many) was Massachusetts state governor Deval Patrick, who announced he was banning Zohydro from his state until its maker Zogenix developed an abuse-deterrent version.

  • FDA releases guidance on how to prevent abuse of opioid painkillers FDA releases guidance on how to prevent abuse of opioid painkillers

    The guidance comes one month after an FDA advisory committee voted against the approval of opioid-containing Zohydro from Zogenix due in part to its potential for abuse. ... Zogenix is currently working on an abuse-deterrent formulation of its drug.

  • Migraine drugs' headache Migraine drugs' headache

    Injectable therapies are invasive and difficult to administer, while other therapies that exist, such as Zogenix's Sumavel DosePro needleless, are considered painful and can result in bruising.

  • Dermatology developments

    Phase II. 130. Durect/Zogenix. Licenses long acting injectable risperidone to combine with Zogenix needle-free system.

  • Next generation

    China . Sumatriptan needle-free injection . Sumavel DosePro (Zogenix, Astellas Pharma). Migraine, cluster headache.

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...